Nasdaq

Positive Treatment Results for Buvidal® in Fentanyl Users Presented at the ASAM 50th Annual Conference

Phase 3 post-hoc analysis indicates less fentanyl and overall illicit opioid use for weekly/monthly buprenorphine depots versus daily standard treatment in a difficult to treat patient population LUND ...
Nasdaq

Camurus Announces New Study Results Showing Superior Patient Reported Outcomes With Buvidal® Versus Standard of Care in Treatment of Opioid Dependence

LUND, Sweden, Nov. 26, 2019 /PRNewswire/ -- Camurus announced today topline results from the 24-week, randomized, controlled, open-label, DEBUT study of weekly and monthly Buvidal® (prolonged-release ...
The Conversation

Buvidal: is it really a ‘game changer’ in the treatment of problematic opioid use?

Katy Holloway receives funding from Welsh Government and is a member of Welsh Government's National Implementation Board for Drug Poisoning Prevention. Fabrizio Schifano receives funding from Welsh ...